| 发明名称 |
Therapeutic Agents and Uses Thereof |
| 摘要 |
The present application provides an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein (for example, PSA or hK2) for use in the treatment of prostate cancer, and a method for the treatment of prostate cancer in a patient, the method comprising the step of administering a therapeutically effective amount of an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein to the patient. |
| 申请公布号 |
US2014286862(A1) |
申请公布日期 |
2014.09.25 |
| 申请号 |
US201214354617 |
申请日期 |
2012.10.26 |
| 申请人 |
FREDAX AB |
发明人 |
Strand Sven-Erik;Tran Amanda Thuy;Axelsson Sven-Niklas Anders |
| 分类号 |
A61K47/48;A61K49/22;A61K49/16;A61K51/10;C07K16/18 |
主分类号 |
A61K47/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An agent comprising or consisting of a binding moiety with specificity for a kallikrein protein for use in the treatment of prostate cancer. |
| 地址 |
Helsingborg SE |
